Screen Reader Mode Icon
Kenya produces strong bioscience research, yet many promising innovations struggle to reach the market, secure regulatory approval, or achieve investment readiness. The Kenya Bio-entrepreneurship Module (KBEM) – supported by the UK Foreign, Commonwealth & Development Office (FCDO) – is being developed as an open, evidence-based, and Kenya-focused resource to strengthen bioscience research-to-market translation across health, agriculture, industry, and environment. This short survey seeks your perspectives on key barriers, decision challenges, researchers and institutional needs shaping bioscience innovation in Kenya. Participation is entirely voluntary, and all responses are anonymous and will be analyzed only in aggregate. Your input will directly inform the design of KBEM tools and guidance to support better researchers, startups, technology transfer offices, and ecosystem partners. The survey takes approximately 6-7 minutes to complete.

Question Title

* 1. Which of the following best describes your current role within the bioscience innovation ecosystem?

Question Title

* 2. In which bioscience domain do you primarily work or engage?

Question Title

* 3. Based on your experience, at which stages do bioscience projects in Kenya most commonly stall or fail to progress toward application or commercialization? (Select up to 3)

Question Title

* 4. Which decisions do bioscience research or innovation teams in Kenya struggle most to make confidently? (Select up to 3)

Question Title

* 5. How confident are you in navigating the following areas without relying on external consultants? (1 = Not confident to 5 = Very confident)

  1 Not Confident 2 Low 3 Moderate 4 High 5 Very High
Intellectual property strategy and ownership
Regulatory and compliance pathways
Market validation and customer discovery
Business model or venture design
Fundability and pitching to investors or donors

Question Title

* 6. In your view, what are the main reasons why bioscience research in Kenya often does not translate into marketable innovations? (Select up to 3)

Question Title

* 7. Who do you believe most strongly influences the direction of bioscience research and innovation priorities in Kenya?

Question Title

* 8. From your experience, which aspects of innovation receive too little attention during early research stages but later become major barriers to commercialization or scale? (Select up to 2)

Question Title

* 9. Where do you see the greatest weaknesses in institutional support systems for bioscience innovation and commercialization in Kenya? (Select up to 2)

Question Title

* 10. Which of the following KBEM tools or resources would be most immediately useful to you or your institution? [Please rank the options from most useful (1) to least useful by dragging them into your preferred order.]

Question Title

* 11. How would you most likely engage with or use the Kenya Bio-entrepreneurship Module (KBEM)?

Question Title

* 12. Is there any additional barrier, opportunity, or priority that you believe KBEM should address to better support bioscience innovation and commercialization in Kenya?

0 of 12 answered
 

T